We have reported that the gene mph(C) (formally referred to as 'mphBM') is located on plasmid pMS97 342 bp downstream of the msr(A) gene. msr(A) specifies resistance to macrolides by ABC-transporter-mediated efflux, and mph(C) has 49% identity to the amino acid sequence of MPH(2P)II, which encodes a phosphotransferase that inactivates some macrolide antibiotics. A strain of Staphylococcus aureus NCTC8325 containing plasmid pMS97 inactivated unlabeled and 14 C-labeled erythromycin when tested by bioautographic and radioautographic techniques. In addition to erythromycin, other 14-membered ring macrolides (except for ketolides), 15-membered ring macrolides and 16-membered ring macrolides, mycinamicin, rosamicin and YM133, were inactivated by the strain. Erythromycin inactivation products produced by the strain carrying pMS97 were completely different from those produced by Escherichia coli BM694 bearing plasmid pAT63, which contains the ereA gene encoding an esterase that hydrolyzes macrolide lactones. Constructs formed with the msr(A) and mph(C) genes, and with the msr(A), mph(C) and erm(Y) genes, showed erythromycin-inactivating activity, but another construct built with the mph(C) gene alone failed to show such activity. This result suggests that any region of the msr(A) gene is needed for the expression of mph(C).
Introduction
Macrolide antibiotics have been widely used for treatment of bacterial infections and many clinical isolates of Staphylococcus aureus strains resistant to macrolides have been reported [1] . It is well known that there are three resistant mechanisms to macrolide antibiotics in staphylococci : modi¢cation of the ribosomal target by a methylase mediated by erm genes [2, 3] , macrolide-speci¢c e¥ux mechanism by the msr(A) gene [4, 5] , and macrolide inactivation by a gene concerned in antibiotics inertness [6^9] .
We have reported that three genes encoding resistance to macrolide^lincosamide^streptogramin B antibiotics (the so-called MLS antibiotics) are located on a single plasmid, pMS97, present in S. aureus [10] . They encode ABC-transporter-mediated e¥ux, inactivation and methylation of 23S rRNA, and have been determined to be arranged in this order. The gene encoding inactivation on plasmid pMS97, mph(C), has 49% identity with the amino acid sequence of MPH(2P)II, which is encoded by mphB from Escherichia coli [11] , but no identity with the amino acid sequence of the macrolide esterase encoded by ereA or ereB from the same strain. The present investigation was conducted to examine the mechanism of regulatory expression of the mph(C) gene on plasmid pMS97 by use of a number of constructs built with the mph(C) gene alone and together with other genes.
Materials and methods

Bacteria, plasmids and media
The bacterial strains and plasmids used in this study are described in Table 1 . Base agar medium for the assay of inactivation consists of brain heart infusion (BHI; Becton Dickinson, USA) containing 50 mM HEPES (N-(2-hydroxyethyl) piperazine-NP-3-propanesulfonic acid), 1% of yeast extract, 0.04% of glucose and 1.5% of agar. Soft agar medium had the same composition as the base agar except for substitution of 0.7% of agar for 1.5%. NBY-M medium consists of nutrient broth (NB ; Becton Dickinson, USA) containing 0.2% yeast extract and 50 mM MOPS (3-morpholinopropanesulfonic acid ; Dojindo Lab., Japan), pH 7.0.
Antibiotics
Erythromycin (EM), oleandomycin (OL), spiramycin, clindamycin hydrochloride (CLDM) and lincomycin were obtained from Japan Upjohn Co. ; azithromycin was from P¢zer Taito Co.; mycinamicin I (MCM) and rokitamycin (RKM) were from Asahi Kasei Co. ; roxithromycin, clarithromycin and telithromycin were from Aventis Pharm Ltd. ; tylosin and CP were from Sigma ; rosamicin was from Yamanouchi Pharmaceutical Co. Ltd ; and YM133 was from Mercian Co. Mikamycin B (MKM-B), a streptogramin type B antibiotic, was prepared as described in a previous paper [12] . [N-methyl- 14 
Antibiotic susceptibility
Minimum inhibitory concentrations (MICs) of MLS antibiotics were determined by the serial two-fold dilution method on Mueller^Hinton agar plates according to the standard method recommended by the Japan Society of Chemotherapy [13] .
Assay for resistance pattern
The disk di¡usion test was applied to the inducibility of resistance by EM and OL to the other MLS drugs as described previously [14] . The amount of drug on each disk was as follows : EM and OL, 10 Wg; RKM and MCM, 20 Wg; CLDM, 5 Wg; and MKM-B, 30 Wg.
Inactivation of EM
Assay for EM inactivation: after overnight culture in NBY-M, cells were harvested by centrifugation at 10 000Ug for 10 min at 4 ‡C. The precipitated cells were resuspended in the same fresh medium containing 10 Wg ml 31 EM and adjusted to a density of 0.1 at OD 620 . Following incubation for 24 h at 37 ‡C, the incubation mixture was passed through a 0.45-Wm nitrocellulose membrane ¢lter. Eighty microliters of ¢ltrate, corresponding to 800 ng of EM before inactivation, was impregnated onto a paper disk of 8-mm diameter, and the disk was dried. Ten milliliters of soft agar containing Micrococcus luteus ATCC9341 (OD 620 of 0.03), as an indicator microorganism, was poured onto a plate in which 40 ml of base agar had previously been allowed to harden. The impregnated disks were laid on top of the plate and incubated at 37 ‡C for 18^20 h.
Radioautograms and bioautograms of EM: a fresh culture of test strain in BHI (2U10 10 cfu) was washed with TMK bu¡er (100 mM Tris^HCl, 10 mM MgCl 2 , 60 mM KCl and 6 mM 2-mercaptoethanol, pH 7.8) [15] . The precipitated cells were resuspended in 100 Wl of the same bu¡er containing [ 14 C]EM, which was diluted to give 10
Wg ml 31 (corresponding to 1 585 dpm Wl 31 at a counting e⁄ciency of 94%) with TMK bu¡er, and incubated at 37 ‡C for 63 h. The culture was centrifuged after incubation, and 10 Wl of supernatant was spotted onto chromatography paper (200 mmU6 mm; 3MM CHR, Whatman), and chromatographed with a solvent system consisting of chloroform^methanol^aqueous ammonia (9:1:0.1). After development, each strip was cut vertically into two equal parts. One of the strips was tested as a bioautogram with M. luteus ATCC9431 as described above. The other was divided into 20 parts from the bottom and radioactivity was counted in a liquid scintillation counter.
Plasmid construction of resistance gene(s)
All DNA manipulations, including digestion with the indicated restriction enzymes, ligation and agarose gel electrophoresis, were carried out by standard procedures [16] . All the gene fragments used for cloning, except for fragment A (12563 bp), were obtained by polymerase chain reaction (PCR) using the primers listed in Table 2 . All primers were synthesized on the basis of the sequence deposited with accession number AB092817.
The PCR reaction mixture consisted of 2.5 U of Taq polymerase, 500 nM of each primer, all four dNTPs at 200 mM each, 1.5 mM MgCl 2 , 20 mM Tris^HCl, pH 8.4, and 50 mM KCl. Plasmid pMS97 as template DNA was added to the PCR reaction mixture and then it was adjusted to a total volume of 100 Wl with distilled water. PCR reaction was performed in a 9600 thermal cycler (Perkin Elmer, Japan) with 165 s of denaturation at 94 ‡C, 30 cycles of 45 s at 94 ‡C, 30 s at 55 ‡C and 45 s at 72 ‡C, and 10 min of extension at 72 ‡C. The ampli¢ed DNA fragment was cloned into the pT7Blue T vector. These recombinant plasmids were digested with XbaI and BamHI, and were ligated into the same site of pND50. The resultant plasmid was transformed into S. aureus RN4220 by electroporation [17] , and transformants were selected with EM and CP. The constructed plasmid with fragment A was prepared by ligation of the largest fragment of plasmid pMS97 digested with PstI with pND50.
Sequencing and DNA analysis
The largest fragment A of plasmid pMS97 digested with PstI was sequenced on an automatic sequencer 377 (Applied Biosystems, Foster City, CA, USA) using the dye termination method. The sequence data were analyzed with the BLAST program. The nucleotide sequence data reported in this paper have been deposited in DDBJ under accession number AB092817.
Results and discussion
3.1. DNA sequencing of largest fragment of plasmid pMS97 after digestion with PstI
We determined the sequence of 12 563 nucleotides representing the largest DNA fragment of plasmid pMS97 after digestion by PstI, which includes the previously described macrolide resistance genes msr(A), mph(C) and erm(Y) [18] . We found eight open reading frames (ORFs; Fig. 1 ) other than the three macrolide resistance genes.
Expression of macrolide resistance genes residing in the constructs
The plasmids constructed by inserting PCR products (3096, 2963, 3778 and 4548 bp) and the PstI-digested fragment (12 563 bp) from pMS97 into vector pND50 were referred to as pND501, pND502, pND5012, pND5013 and pND50A, respectively (Fig. 1 ). They were transformed a Constructs containing the genes of macrolide resistance are illustrated in Fig. 1.  b The positions of primers are based on their location in the sequence deposited with accession number AB092817.
into S. aureus RN4220 by electroporation. The transformants were tested for susceptibility to MLS antibiotics in terms of disk di¡usion and determination of MIC. Fig. 2 shows susceptibility patterns to MLS antibiotics in the representative transformants (S. aureus RN4220 containing pND501, pND502 and pND50A). Strain S. aureus 4220(pND501) formed 'D-shaped' inhibition zones around both MCM and MKM-B disks because EM and OL induced resistance to MCM and MKM-B as a result of the presence of the msr(A) gene (formally referred to as 'msrSAP') [10] (Fig. 2A) . A similar phenotypic pro¢le was obtained in S. aureus 4220(pND5012) despite the presence of mph(C) in the construct plasmid. S. aureus 4220(pND502) produced a circular inhibition zone around all disks (Fig. 2B ) similar to those of the host strain RN4220. If inactivation of any macrolide antibiotics by the product encoded by mph(C) residing on plasmid pND502 were to occur, no inhibition zone would appear around the corresponding disks. We could ¢nd no di¡er-ences in the size and shape of inhibition zone between these two strains (S. aureus RN4220 and S. aureus 4220(pND502)). S. aureus 4220(pND50A) shows inducible resistance to RKM, MCM, CLDM, and MKM-B by EM, and its resistance to those antibiotics except for RKM and CLDM is also induced by OL. This suggests that, in the presence of a low concentration of EM, the erm(Y) gene could be expressed at the highest e⁄ciency of the three genes ( Fig. 2C and Table 3 ). In addition, S. aureus 4220(pMS97) and S. aureus 4220(pND5013) also exhibited the same disk pattern as S. aureus 4220(pND50A). In our previous paper [18] , we reported that S. aureus RN4220 containing the constructed plasmid pND503 with erm(Y) alone showed exemplary EM-inducible resistance to MLS antibiotics. The MICs of MLS antibiotics were determined in all strains containing the constructs used in these studies (Table 3). All of these strains, containing any of the constructed plasmids, showed approximately the same susceptibility (MIC determined after 18^20 h incubation) to MCM, RKM, CLDM and MKM-B as the host strain S. aureus RN4220. The strains containing the constructed plasmids, except for S. aureus 4220(pND502), displayed high MICs for EM and OL approximately similar to those of S. aureus 4220(pMS97). However, strains S. aureus 4220(pND50A) and S. aureus 4220(pND5013), which bear the three genes msr(A)-mph(C)-erm(Y), exhibited MICs for EM (400 Wg ml 31 ) and OL (50 Wg ml 31 ) particularly close to those of S. aureus 4220(pMS97) (800 Wg ml 31 for EM and 50 Wg ml 31 for OL). This appears to indicate a phenotypic precedence of the erm(Y) gene over the other genes, msr(A) and mph(C), as illustrated by the results in panels A and C in Fig. 2 . S. aureus 4220(pND501), which has only a single resistance gene, msr(A), showed resistance to EM and OL of 100 Wg ml 31 . On the contrary, S. aureus 4220(pND502), which has the single mph(C) gene, showed the same susceptibility to EM (0.39 Wg ml 31 ) and OL (1.56 Wg ml 31 ) as the host strain S. aureus RN4220. This suggests that mph(C) alone appears insu⁄cient to express resistance to the drugs. This observation of the null-like expression of the mph(C) gene was further supported by the fact that S. aureus 4220(pND501), bearing only msr(A) and S. aureus 4220(pND5012), bearing msr(A) and mph(C), attained approximately the same MICs for EM (100 Wg ml 31 ) and OL (100 Wg ml 31 ).
Inactivation assay
Inactivation of [ 14 C]EM by S. aureus 8325(pMS97) was examined by radioautogram and bioautogram assays. 14 C-labeled EM was chromatographed with the indicated solvent on Whatman 3MM chromatography paper, and the developed chromatogram was split into half (each part 3 mm in width). Radioautography of one half of the paper showed a single peak of radioactivity at 15 cm from the origin (illustrated graphically in Fig. 3 ). When the other half of the paper was assayed by bioautography using M. luteus as the indicator microorganism, we detected antibiotic activity at the same position as the radioactivity (panel A in Fig. 3 ). In contrast, a supernatant sample from a mixture of E. coli BM694(pAT63) and [ 14 C]EM incubated for 63 h gave one peak at a position of about 13 cm, but antibacterial activity in the corresponding position had been lost (panel B in Fig. 3 ). Similarly, a supernatant sample from a mixture of S. aureus 8325(pMS97) and [ 14 C]EM incubated for 63 h gave at least two peaks at 0 and 5 cm from the origin. In fact, the 24-h supernatant from the same mixture gave three peaks (data not shown). The transient peak was seen at about 3 cm from the origin, and was gradually lost with time with a corresponding increase in the more mobile peak at 5 cm. These results suggest that the inactivation products produced by the mph(C) gene are greatly di¡er-ent from those produced by the ere gene from E. coli BM694(pAT63).
We further examined mph(C)-dependent inactivation of a range of MLS antibiotics, including 14-, 15-and 16-membered macrolides, to determine the spectrum of drugs capable of being inactivated by Mph(C) ( Table 4) . Inactivation (%) was calculated from the activity of residual drug after incubation with S. aureus 8325(pMS97) or In order to more clearly understand the conditions under which the mph(C) gene functions, EM was incubated with the indicated strains carrying the constructed plasmids for 24 h at 37 ‡C and the residual activity of EM present in the ¢ltrate was determined by disk di¡usion assay (data not shown). Host strain S. aureus RN4220 and strain S. aureus 4220(pND502) did not inactivate EM. The other strains, including strain E. coli BM694(pAT63), inactivated EM. This observation suggests that any region of the msr(A) gene is needed for the expression of the mph(C). Although a promoter-like sequence of mph(C) is present in the immediate vicinity upstream of the coding sequence, the gene alone was not expressed even in the presence of EM. There are possible explanations for our observation of the phenotypic absence of activity of the Mph(C) protein: the promoter just upstream of mph(C) is not recognized by staphylococcal DNA-dependent RNA polymerase; or Mph(C) protein is particularly proteaselabile. Table 4 Comparison of the spectrum of MLS-antibiotic inactivation after about 60 h of incubation with S. aureus NCTC8325 containing mph(C) located in plasmid pMS97 and E. coli BM694 containing ereA located in plasmid pAT63 
